Furthermore, we observed the enhanced secretory phenotype of cancer cells with massive production of pro-inflammatory cytokines, IL1β, IL6 and IL8, as well as death ligands, FAS-L and TRAIL, after combined treatment of GBM cells. This evidence concerns the gene FASLG and glioblastoma.